Board Meeting12 May 2026, 03:06 pm
Marksans Pharma Board Meeting on May 26, 2026
AI Summary
Marksans Pharma Ltd has scheduled a Board of Directors meeting on May 26, 2026, in Mumbai, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a dividend on equity shares for the financial year 2025-26, if any. The trading window for dealing in the company's shares has been closed from April 1, 2026, and will remain closed until May 28, 2026.
Key Highlights
- Board meeting scheduled for May 26, 2026, to approve audited financial results.
- Consideration of dividend on equity shares for FY 2025-26 is on the agenda.
- Trading window closed from April 1, 2026, to May 28, 2026, for designated persons.
- Meeting details available on the company's website and stock exchanges.
Price Impact
More from MARKSANS